Resultados de la búsqueda 1571-1580 of 4689 for Comparative genomics

  1. Oncología (médica) - Ensayos clínicos

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

  2. Oncología (médica) - Ensayos clínicos

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...

  3. Oncología (médica) - Ensayos clínicos

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  4. Oncología (médica) - Ensayos clínicos

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  5. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated tumor ...

  9. Oncología (médica) - Ensayos clínicos

    Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer ...

  10. Oncología (médica) - Ensayos clínicos

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...